Karyopharm Therapeutics Inc.

NASDAQ:KPTI

0.9032 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 42.78633.12633.74736.00937.57938.69833.5836.14539.67947.67126.26937.68922.60123.2635.121.33333.51418.13818.09613.1499.4930.1550.2060.23919.891101.53400.0030.0680.0470.0480.05900.0250.0750.1500.0160.0210.0210.1710.02100.1330.2330.0330.034
Cost of Revenue 1.5561.9961.5630.9111.1941.3511.8680.980.9391.4260.7420.5891.1380.9331.0520.4380.3960.8191.3941.01326.51737.97438.8936.42744.73441.32134.83325.23723.1224.08320.67119.89324.57921.79524.06425.92327.00620.7510.00115.95113.15910.9799.6897.7386.064.9653.6660
Gross Profit 41.2331.1332.18435.09836.38537.34731.71235.16538.7446.244125.52737.121.46322.32734.04820.89533.11817.31916.70212.136-17.024-37.819-38.684-36.188-24.843-31.321-33.299-25.237-23.117-24.015-20.624-19.845-24.52-21.795-24.039-25.848-26.856-20.7510.015-15.93-13.138-10.808-9.668-7.738-5.927-4.732-3.6330.034
Gross Profit Ratio 0.9640.940.9540.9750.9680.9650.9440.9730.9760.970.9940.9840.950.960.970.9790.9880.9550.9230.923-1.793-243.994-187.786-151.414-1.249-3.132-21.7070-7,705.667-353.162-438.809-413.438-415.5930-961.56-344.64-179.0400.938-758.571-625.619-63.205-460.3810-44.564-20.309-110.0911
Reseach & Development Expenses 38.2835.3439.30435.55331.47732.33930.93231.35944.30942.06244.00345.80833.98137.0537.18537.03742.59433.99731.57926.2726.51737.97438.8936.42744.73441.32134.83325.23723.1224.08320.67119.89324.57921.79524.06425.92327.00620.75120.03815.95113.15910.9799.6897.7386.064.9653.6662.997
General & Administrative Expenses 31.0729.54930.68830.80534.48135.90734.64934.64537.33938.768000030.6780030.67828.38925.26724.66227.10318.77112.9669.4897.6216.1535.8186.6356.2646.5415.8975.9565.5545.2644.7626.1575.3995.923.8143.312.9042.481.5830.9430.8790.6050.672
Selling & Marketing Expenses 000000000000003.251000000000000000000000000000000000
SG&A 31.0729.54930.68830.80534.48135.90734.64934.64537.33938.76834.56235.10436.5337.6533.92930.96730.84330.67828.38925.26724.66227.10318.77112.9669.4897.6216.1535.8186.6356.2646.5415.8975.9565.5545.2644.7626.1575.3995.923.8143.312.9042.481.5830.9430.8790.6050.672
Other Expenses 14.2960.196-0.2110.0890.03-0.264-0.0130.016-0.013-0.073-0.4780.0180.436-0.0610.383-0.141-0.0610.025-0.0140.01-0.044-0.002-0.013-0.0130.007-0.014-0.011-0.026-0.029-0.0150.0110.006-0.0110.0040.007-0.0020.051-0.058-0.027000000000
Operating Expenses 69.3564.88969.99266.35865.95868.24665.58166.00481.64880.8378.56580.91270.51174.771.11468.00473.43764.67559.96851.53751.17965.07757.66149.39354.22348.94240.98631.05529.75530.34727.21225.7930.53527.34929.32830.68533.16326.1525.95819.76516.46913.88312.1699.3217.0035.8444.2713.669
Operating Income -28.12-33.759-37.808-31.26-29.573-30.899-33.869-30.839-42.908-34.58646.962-43.812-49.048-52.373-37.066-47.109-40.319-47.356-43.266-39.401-41.686-64.922-57.455-49.154-34.332-38.942-39.452-31.055-29.752-30.279-27.165-25.742-30.476-27.349-29.303-30.61-33.013-26.15-25.942-19.744-16.448-13.712-12.148-9.321-6.87-5.611-4.238-3.635
Operating Income Ratio -0.657-1.019-1.12-0.868-0.787-0.798-1.009-0.853-1.081-0.7260.372-1.162-2.17-2.252-1.056-2.208-1.203-2.611-2.391-2.997-4.391-418.852-278.908-205.665-1.726-3.894-25.7180-9,917.333-445.279-577.979-536.292-516.5420-1,172.12-408.133-220.0870-1,621.375-940.19-783.238-80.187-578.4760-51.654-24.082-128.424-106.912
Total Other Income Expenses Net 51.979-3.532-3.8990.0890.03-3.173-4.564-5.44-0.013-6.683-0.4780.0180.436-0.0610.383-0.141-0.0610.025-0.0140.01-0.044-0.002-0.013-0.0130.007-0.014-0.011-0.026-0.029-0.0150.0110.006-0.0110.0040.007-0.0020.051-0.058-0.0270.020.0170.0180.00200.001000
Income Before Tax 23.859-37.291-41.707-34.494-32.503-34.072-38.433-36.279-48.941-41.26938.599-51.706-53.448-57.265-43.359-53.451-46.289-52.865-48.645-41.347-43.407-66.151-58.193-48.069-33.672-38.447-39.031-30.627-29.369-29.894-26.796-25.425-30.158-27.059-29.046-30.373-32.695-26.067-25.928-19.724-16.431-13.694-12.146-9.321-6.869-5.611-4.238-3.635
Income Before Tax Ratio 0.558-1.126-1.236-0.958-0.865-0.88-1.145-1.004-1.233-0.8660.306-1.372-2.365-2.462-1.235-2.506-1.381-2.915-2.688-3.144-4.573-426.781-282.49-201.126-1.693-3.845-25.4440-9,789.667-439.618-570.128-529.688-511.1530-1,161.84-404.973-217.9670-1,620.5-939.238-782.429-80.082-578.3810-51.647-24.082-128.424-106.912
Income Tax Expense 0.0670.0710.130.0120.1270.0540.0730.0450.1210.13-0.1210.1060.1340.1490.0620.0440.1370.0660.0020.020.0080.010.0170.014-0.0170.0120.0090.0130.0180.0230.139-0.317-0.318-0.29-0.257-0.237-0.318-0.083-0.015-0.02-0.017-0.018-0.0020-0.001000
Net Income 23.792-37.362-41.837-34.506-32.63-34.126-38.506-36.324-49.062-41.39938.72-51.812-53.582-57.414-43.421-53.495-46.426-52.931-48.647-41.367-43.415-66.161-58.21-48.083-33.655-38.459-39.04-30.64-29.387-29.917-26.935-25.425-30.158-27.059-29.046-30.373-32.695-26.067-25.928-19.724-16.431-13.694-12.146-9.321-6.869-5.611-4.238-3.635
Net Income Ratio 0.556-1.128-1.24-0.958-0.868-0.882-1.147-1.005-1.236-0.8680.307-1.375-2.371-2.468-1.237-2.508-1.385-2.918-2.688-3.146-4.573-426.845-282.573-201.184-1.692-3.846-25.450-9,795.667-439.956-573.085-529.688-511.1530-1,161.84-404.973-217.9670-1,620.5-939.238-782.429-80.082-578.3810-51.647-24.082-128.424-106.912
EPS 0.2-0.32-0.36-0.3-0.29-0.3-0.43-0.45-0.62-0.530.51-0.69-0.71-0.77-0.59-0.73-0.63-0.78-0.76-0.67-0.71-1.09-0.96-0.79-0.6-0.78-0.8-0.65-0.64-0.71-0.65-0.69-0.84-0.75-0.81-0.85-0.92-0.74-0.79-0.61-0.55-0.46-0.41-3.66-2.86-2.52-0.43-1.97
EPS Diluted -0.2-0.32-0.36-0.3-0.29-0.3-0.43-0.45-0.62-0.530.46-0.69-0.71-0.77-0.59-0.73-0.63-0.78-0.76-0.67-0.71-1.09-0.96-0.79-0.6-0.78-0.8-0.65-0.64-0.71-0.65-0.69-0.84-0.75-0.81-0.85-0.92-0.74-0.79-0.61-0.55-0.46-0.41-3.66-2.86-2.52-0.43-1.97
EBITDA -28.029-33.674-37.731-28.421-26.636-28.314-32.548-30.165-42.479-34.40846.539-43.51-48.218-51.935-36.287-46.415-39.293-46.114-42.178-38.011-40.318-62.908-55.7-48.966-34.148-38.773-39.452-30.879-29.572-30.279-27.165-25.563-30.297-27.17-29.303-30.445-32.857-26.15-25.927-19.638-16.406-13.669-12.108-9.284-6.835-5.577-4.208-3.601
EBITDA Ratio -0.655-1.017-1.118-0.789-0.709-0.732-0.969-0.835-1.071-0.7220.369-1.154-2.133-2.233-1.034-2.176-1.172-2.542-2.331-2.891-4.247-405.858-270.388-204.879-1.717-3.877-25.7180-9,857.333-445.279-577.979-532.563-513.5080-1,172.12-405.933-219.0470-1,620.438-935.143-781.238-79.936-576.5710-51.391-23.936-127.515-105.912